XOMA Royalty Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About XOMA Royalty Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
/ 
Frequently asked questions
To buy XOMA Royalty Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for XOMA Royalty Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for XOMA Royalty Corp. is XOMA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
XOMA Royalty Corp. has its primary listing on NASDAQ. You can trade XOMA Royalty Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, XOMA Royalty Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include XOMA Royalty Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like XOMA Royalty Corp..